Cardiovascular Disease
Baker Heart and Diabetes Institute is an international leader in cardiovascular research.
Programs extend from laboratory to clinical research and wide-scale national and international community studies, with a focus on diagnosis, prevention and treatment.
Read more on Baker Institute’s cardiovascular research programs
Other Alliance research in Cardiovascular Disease
- The Monash University Department of Epidemiology and Preventive Medicine (DEPM) is coordinating the ASPREE (ASPirin in Reducing Events in the Elderly) study. ASPREE is the largest primary prevention study ever undertaken in elderly Australians and will determine whether aspirin can help prevent or delay the onset of common age-related disease including cardiovascular disease.
- Research undertaken at Alfred Health Cardiology Research and Clinical Trials includes structural heart disease, acute coronary syndromes and non-invasive imaging
- Monash Centre of Cardiovascular Research & Education in Therapeutics – multi-national heart failure prevention trials.
Spotlight on cardiac research
Illicit drug use involved in nearly one in three sudden cardiac deaths in young adults
Approximately one-third of young adults in Victoria who experienced sudden cardiac deaths outside of a hospital from 2019 to 2021 used illicit drugs prior to their fatal events, a study led by Dr Liz Paratz, at the Baker Heart and Diabetes Institute has found.